Cardiology
From the Journals
DOACs’ safety affirmed in real-world setting
Direct oral anticoagulants were linked with lower bleeding risk, regardless of reason for use. One shone brightest.
Audio
DOJ lawsuit reins in inappropriate ICD use
ATLAS reanalysis shows rivaroxaban in a different light; cerebral protection may be best for all TAVRs; and more in MDedge Cardiocast.
Guidelines
New pediatric hypertension guidelines increased hypertension prevalence
One-quarter of those classified as having elevated BP in the 2004 guideline were reclassified as having stage 1 hypertension.
From the Journals
New look at ATLAS suggests rivaroxaban may still have role in ACS
A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.
Commentary
The problem with blood pressure guidelines
Evidence-based guidelines differ from evidence-informed guidelines.
Applied Evidence
Blood pressure targets: How low should you go (and for whom)?
The ACC/AHA's lower BP goals are supported by previously unavailable evidence, the strongest of which is for patients with CVD. But others can...
News
High-bleeding-risk AF patients cut stroke risk with Amplatzer Amulet
Latest News
Heart failure confers poor prognosis in rheumatoid arthritis
AMSTERDAM – Smoking, insufficiently controlled inflammation, and glucocorticoid use were risk factors for heart failure hospitalization and death...
Conference Coverage
Alirocumab’s benefit greater in diabetes patients: ODYSSEY Outcomes
ORLANDO – Results aren’t surprising considering extra risk in this population.
From the Journals
Could tackling maternal obesity prevent later CVD in offspring?
Most evidence supporting this hypothesis comes from animal studies.
Audio
Ethical violations scuttle NIH’s big alcohol study
A controversial AAA screening study; curbing CV risk in diabetes with healthy habits; invasive cardiologists get top starting salaries; and more...